Jennison Associates LLC Nektar Therapeutics Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$30.43 - $56.65 $378,336 - $704,329	-12,433 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$46.46 - $68.49 $577,637 - $851,536	12,433 New	12,433 $758,000
Q2 2018 Aug 02, 2018	SELL	$46.25 - $104.45 $17.8 Million - $40.2 Million	-384,978 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$57.4 - $108.44 $7.55 Million - $14.3 Million	131,562 Added 51.92%	384,978 $40.9 Million
Q4 2017 Jan 25, 2018	BUY	$23.02 - $60.5 $5.83 Million - $15.3 Million	253,416	253,416 $15.1 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $247M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.